RT Journal Article
SR Electronic
T1 Quantitatively assessing early detection strategies for mitigating COVID-19 and future pandemics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.08.23291050
DO 10.1101/2023.06.08.23291050
A1 Liu, Andrew Bo
A1 Lee, Daniel
A1 Jalihal, Amogh Prabhav
A1 Hanage, William P.
A1 Springer, Michael
YR 2023
UL http://medrxiv.org/content/early/2023/10/06/2023.06.08.23291050.abstract
AB Researchers and policymakers have proposed systems to detect novel pathogens earlier than existing surveillance systems by monitoring samples from hospital patients, wastewater, and air travel, in order to mitigate future pandemics. How much benefit would such systems offer? We developed, empirically validated, and mathematically characterized a quantitative model that simulates disease spread and detection time for any given disease and detection system. We find that hospital monitoring could have detected COVID-19 in Wuhan 0.4 weeks earlier than it was actually discovered, at 2,300 cases (standard error: 76 cases) compared to 3,400 (standard error: 161 cases). Wastewater monitoring would not have accelerated COVID-19 detection in Wuhan, but provides benefit in smaller catchments and for asymptomatic or long-incubation diseases like polio or HIV/AIDS. Monitoring of air travel provides little benefit in most scenarios we evaluated. In sum, early detection systems can substantially mitigate some future pandemics, but would not have changed the course of COVID-19.Competing Interest StatementWPH is a member of the scientific advisory board and has stock options in BioBot Analytics. MS is a cofounder of Rhinostics and consults for the diagnostic consulting company Vectis Solutions LLC. The other authors declare that they have no competing interests.Funding StatementThis study was funded by: Lynch Foundation Fellows Program in Systems Biology at Harvard Medical School (ABL) National Library of Medicine grant T15LM007092 (DL) National Institutes of Health grant R01GM120122 (APJ) CDC contract 200-2016-91779 (WPH) National Institutes of Health grant R01GM120122 (MS) This project has been funded (in part) by contract 200-2016-91779 with the Centers for Disease Control and Prevention. Disclaimer: The findings, conclusions, and views expressed are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData are available in the supplement and at https://github.com/abliu/early-detection/releases.